0
     

Report Added
Report already added
Yifan Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report

Yifan Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report

Summary

Yifan Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Yifan Pharmaceutical Co Ltd (Yifan) develops, manufactures, markets active pharmaceutical ingredients, medical products and polymer materials. The company’s products include Chinese traditional medicines, women’s health medicines, dermatological medicines, paediatric medicines, blood tumor drugs, feed additive and animal health products, skin and hair care ingredients, functional food additives and fine chemicals, among others. The company develops products based on its proprietary DiKine dimeric cytokine platform and iTab immune therapy antibody platform. Its pipeline products are targeted for the treatment of neutropenia, alcoholic hepatitis, acute pancreatitis, solid tumors, B-cell leukaemia, and others. Yifan is headquartered in Hangzhou, Zhejiang, China

Scope

- Detailed information on Yifan Pharmaceutical Co Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Yifan Pharmaceutical Co Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Yifan Pharmaceutical Co Ltd including a breakdown and examination of key business segments
- Intelligence on Yifan Pharmaceutical Co Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Yifan Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Yifan Pharmaceutical Co Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Yifan Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Yifan Pharmaceutical Co Ltd's business structure, strategy and prospects.

Table of Contents

Company Snapshot
Yifan Pharmaceutical Co Ltd: Company Overview
Yifan Pharmaceutical Co Ltd: Overview and Key Facts
Yifan Pharmaceutical Co Ltd: Overview
Yifan Pharmaceutical Co Ltd: Key Facts
Yifan Pharmaceutical Co Ltd: Key Employees
Yifan Pharmaceutical Co Ltd: Major Products and Services
Yifan Pharmaceutical Co Ltd: Company History
Yifan Pharmaceutical Co Ltd: Locations and Subsidiaries
Yifan Pharmaceutical Co Ltd: Key Competitors
Yifan Pharmaceutical Co Ltd: Company Analysis
Yifan Pharmaceutical Co Ltd: Business Description
Yifan Pharmaceutical Co Ltd: SWOT Analysis
Yifan Pharmaceutical Co Ltd: SWOT Overview
Yifan Pharmaceutical Co Ltd: Strengths
Yifan Pharmaceutical Co Ltd: Weaknesses
Yifan Pharmaceutical Co Ltd: Opportunities
Yifan Pharmaceutical Co Ltd: Threats
Yifan Pharmaceutical Co Ltd: Corporate Financial Deals Activity
Yifan Pharmaceutical Co Ltd: Financial Deals Overview
Yifan Pharmaceutical Co Ltd: Targets and Partners
Yifan Pharmaceutical Co Ltd: Top Deals 2018 - 2022YTD*
Yifan Pharmaceutical Co Ltd: Corporate Venturing
Yifan Pharmaceutical Co Ltd: Partnership
Yifan Pharmaceutical Co Ltd: Recent Developments
Yifan Pharmaceutical Co Ltd: News and Events Summary
Yifan Pharmaceutical Co Ltd: Financial Deals
Yifan Pharmaceutical Co Ltd: Regulatory and Legal Events
Yifan Pharmaceutical Co Ltd: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Yifan Pharmaceutical Co Ltd: Key Facts
Table 2: Yifan Pharmaceutical Co Ltd: Key Employees
Table 3: Yifan Pharmaceutical Co Ltd: Company History
Table 4: Yifan Pharmaceutical Co Ltd: Locations and Subsidiaries
Table 5: Yifan Pharmaceutical Co Ltd: Key Competitors
Table 6: Yifan Pharmaceutical Co Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Yifan Pharmaceutical Co Ltd: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 8: Yifan Pharmaceutical Co Ltd: Targets and Partners
Table 9: Yifan Pharmaceutical Co Ltd: Top Deals 2018 - 2022YTD*
Table 10: Yifan Pharmaceutical Co Ltd: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 11: Yifan Pharmaceutical Co Ltd: Corporate Venturing by Geography (2018 - YTD*2022)
Table 12: Yifan Pharmaceutical Co Ltd: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 13: Yifan Pharmaceutical Co Ltd: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 14: Yifan Pharmaceutical Co Ltd: News and Events Summary
Table 15: Yifan Pharmaceutical Co Ltd: Financial Deals
Table 16: Yifan Pharmaceutical Co Ltd: Regulatory and Legal Events
Table 17: Yifan Pharmaceutical Co Ltd: Research & Development

List of Figures
Figure 1: Yifan Pharmaceutical Co Ltd: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Yifan Pharmaceutical Co Ltd: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 3: Yifan Pharmaceutical Co Ltd: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 4: Yifan Pharmaceutical Co Ltd: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 5: Yifan Pharmaceutical Co Ltd: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 6: Yifan Pharmaceutical Co Ltd: Partnership Trend by Deal Type (2018 - YTD*2022)

Report Title: Yifan Pharmaceutical Co Ltd - Strategy, SWOT and Corporate Finance Report


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Vietnam Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Venezuela Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for US Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Uruguay Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for United Arab Emirates Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2023 What's Next for Ukraine Diagnostics Market?--2022 Supplier Shares and Strategies, 2022-2027 Volume and Sales Forecasts for 500 Tests--Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM